Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived Stem Cells in the Treatment of Acute Burns (ASCAB)
2018-002870-27Phase 2Terminated
- Sponsor
- Rigshospitalet
- Start
- Sep 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of CSCC_ASC in burn injury, sponsored by Rigshospitalet. Primary endpoint: burn degree of healing. Started Sep 2018; status: terminated.
02
Drugs
CSCC_ASC
03
Conditions
burn injury
Beyond the preview
Go deeper on 2018-002870-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002870-27.